Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda clinical programs — 1179 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
1179
Drugs
359
Patents
1436
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Takeda projects

1,179 ClinicalTrials.gov programs sponsored by Takeda.

Takeda has 1,179 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,179 programs

Clinical programs

Page 19 of 25

  1. SSP-004184

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  2. SSP-004184AQ

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  3. SSP-004184SS

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  4. SYR-472

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  5. Sapanisertib

    Takeda

    Non-hematologic Malignancy

    phase 1 small molecule completed

    1 trial

  6. Scopolamine

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  7. Simvastatin

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  8. Soticlestat

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    4 trials

  9. Soticlestat

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  10. Soticlestat 300 mg

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. TAK-004

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  12. TAK-007

    Takeda

    Refractory Lupus Nephritis

    phase 1 mab terminated

    1 trial

  13. TAK-020

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  14. TAK-020 Captisol Oral Solution

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  15. TAK-058

    Takeda

    Schizophrenia

    phase 1 small molecule terminated

    1 trial

  16. TAK-058

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  17. TAK-058 (ENV8058)

    Takeda

    Dose Finding Study

    phase 1 small molecule completed

    1 trial

  18. TAK-063

    Takeda

    Schizophrenia

    phase 1 small molecule completed

    1 trial

  19. TAK-063

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. TAK-071

    Takeda

    Alzheimer Disease

    phase 1 small molecule terminated

    1 trial

  21. TAK-079

    Takeda

    Autoimmune Disease

    phase 1 small molecule completed

    1 trial

  22. TAK-079

    Takeda

    Multiple Myeloma

    phase 1 small molecule completed

    1 trial

  23. TAK-079

    Takeda

    Systemic Lupus Erythematosus

    phase 1 small molecule completed

    1 trial

  24. TAK-079-1006

    Takeda

    IgAN is Primary Immunoglobulin A Nephropathy (IgAN) (also known as Berger's disease)

    phase 1 other active

    1 trial

  25. TAK-102

    Takeda

    Solid Tumors

    phase 1 mab terminated

    1 trial

  26. TAK-103

    Takeda

    Solid Tumors

    phase 1 mab terminated

    1 trial

  27. TAK-105-a

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  28. TAK-114 10 mg capsule

    Takeda

    Clinical Pharmacology

    phase 1 small molecule completed

    1 trial

  29. TAK-117

    Takeda

    Metastatic Solid Tumors

    phase 1 small molecule completed

    1 trial

  30. TAK-117

    Takeda

    Neoplasm, Advanced or Metastatic

    phase 1 small molecule completed

    1 trial

  31. TAK-123

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  32. TAK-137

    Takeda

    Attention-Deficit/Hyperactivity Disorder

    phase 1 small molecule terminated

    1 trial

  33. TAK-137

    Takeda

    Dose Finding Study

    phase 1 small molecule completed

    1 trial

  34. TAK-137 5 mg tablet, TAK-137 placebo tablet

    Takeda

    Healthy Japanese Adult Male

    phase 1 small molecule terminated

    1 trial

  35. TAK-164

    Takeda

    Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies

    phase 1 small molecule terminated

    1 trial

  36. TAK-165

    Takeda

    Breast Neoplasm

    phase 1 small molecule completed

    1 trial

  37. TAK-227

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  38. TAK-228

    Takeda

    Advanced Nonhematologic Malignancies

    phase 1 small molecule completed

    1 trial

  39. TAK-233

    Takeda

    Clinical Pharmacology

    phase 1 small molecule completed

    1 trial

  40. TAK-272

    Takeda

    Japanese Healthy Adult Males

    phase 1 small molecule completed

    1 trial

  41. TAK-272

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  42. TAK-279

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  43. TAK-279

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  44. TAK-279

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  45. TAK-329

    Takeda

    Type 1 Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  46. TAK-385

    Takeda

    Hormone Treatment-naïve Participants With Prostate Cancer

    phase 1 small molecule completed

    1 trial

  47. TAK-385 40 mg

    Takeda

    Japanese Premenopausal Healthy Adult Women

    phase 1 small molecule completed

    1 trial

  48. TAK-385 T2 Formulation

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Takeda have?

1,179 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.